Clinical Trial Update: Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for recombinant bovine basic fibroblast growth factor as a treatment for radiation-induced oral mucositis (stomatitis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis
• Stomatitis

Drugs mentioned

• Recombinant bovine basic fibroblast growth factor (basic fibroblast growth factor)

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Stomatitis | Phase 2 | Status: UNKNOWN